Affinity Capital Advisors, LLC Renovo Rx, Inc. Transaction History
Affinity Capital Advisors, LLC
- $515 Million
- Q3 2024
A detailed history of Affinity Capital Advisors, LLC transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Affinity Capital Advisors, LLC holds 13,279 shares of RNXT stock, worth $17,262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,279
Previous 13,279
-0.0%
Holding current value
$17,262
Previous $15,000
6.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RNXT
# of Institutions
16Shares Held
2.87MCall Options Held
0Put Options Held
0-
Bank Of Montreal Toronto, A6975KShares$1.27 Million0.0% of portfolio
-
Bank Of The West975KShares$1.27 Million0.27% of portfolio
-
Adar1 Capital Management, LLC Austin, TX315KShares$409,7490.05% of portfolio
-
Geode Capital Management, LLC Boston, MA233KShares$302,8180.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$126,3140.01% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $11.8M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...